New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study suggests new strategy for treating advanced, progressing bile duct cancer

Study suggests new strategy for treating advanced, progressing bile duct cancer

byOhio State University Medical CenterCredit: Ohio State University Medical CenterA new study led by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer H
Oncology December 22,2023
Study suggests new strategy for treating advanced, progressing bile duct cancer

Study suggests new strategy for treating advanced, progressing bile duct cancer

byOhio State University Medical CenterCredit: Ohio State University Medical CenterA new study led by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer H
Oncology December 22,2023
Mutations in donors' stem cells may cause problems for cancer patients

Mutations in donors' stem cells may cause problems for cancer patients

byWashington University School of MedicineA new study from Washington University School of Medicine in St. Louis suggests that bone marrow -- or blood stem cells -- from healthy donors can harbo
Oncology December 22,2023
Mutations in donors' stem cells may cause problems for cancer patients

Mutations in donors' stem cells may cause problems for cancer patients

byWashington University School of MedicineA new study from Washington University School of Medicine in St. Louis suggests that bone marrow -- or blood stem cells -- from healthy donors can harbo
Oncology December 22,2023
Two genes slow down the development of intestinal tumors

Two genes slow down the development of intestinal tumors

byThe Francis Crick InstituteImage of two intestinaltumours, one a control (top) and one with the genes NEDD4 and NEDD4L deleted (bottom). Credit: The Francis Crick InstituteBenign i
Oncology December 22,2023
Two genes slow down the development of intestinal tumors

Two genes slow down the development of intestinal tumors

byThe Francis Crick InstituteImage of two intestinaltumours, one a control (top) and one with the genes NEDD4 and NEDD4L deleted (bottom). Credit: The Francis Crick InstituteBenign i
Oncology December 22,2023
Defensive beliefs likely keep people from taking at-home stool tests that screen for colorectal cancer

Defensive beliefs likely keep people from taking at-home stool tests that screen for colorectal cancer

byWileyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer is one of the most treatable cancers, especially if it is detected early; however, many
Oncology December 22,2023
Defensive beliefs likely keep people from taking at-home stool tests that screen for colorectal cancer

Defensive beliefs likely keep people from taking at-home stool tests that screen for colorectal cancer

byWileyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer is one of the most treatable cancers, especially if it is detected early; however, many
Oncology December 22,2023
Cancers engaged in evolutionary arms race with immune system

Cancers engaged in evolutionary arms race with immune system

byInstitute of Cancer ResearchMultiplex immunohistochemistry image of T-cells infiltrating stomach tumours. Credit: Katharina von Loga, Biomedical Research CentreAggressive, highly mutated cance
Oncology December 22,2023
Cancers engaged in evolutionary arms race with immune system

Cancers engaged in evolutionary arms race with immune system

byInstitute of Cancer ResearchMultiplex immunohistochemistry image of T-cells infiltrating stomach tumours. Credit: Katharina von Loga, Biomedical Research CentreAggressive, highly mutated cance
Oncology December 22,2023
Finding community online after finding a lump: Social media and younger adults with cancer

Finding community online after finding a lump: Social media and younger adults with cancer

by Jaigris Hodson and Cheryl Heykoop,The ConversationCredit: AI-generated imageOctober marks Breast Cancer Awareness Month. The Canadian Cancer Society estimates thatone in eight women wil
Oncology December 22,2023
Finding community online after finding a lump: Social media and younger adults with cancer

Finding community online after finding a lump: Social media and younger adults with cancer

by Jaigris Hodson and Cheryl Heykoop,The ConversationCredit: AI-generated imageOctober marks Breast Cancer Awareness Month. The Canadian Cancer Society estimates thatone in eight women wil
Oncology December 22,2023
New link between fatal muscle wasting disease gene and cancer discovered

New link between fatal muscle wasting disease gene and cancer discovered

byUniversity of PortsmouthCredit: Unsplash/CC0 Public DomainMutations of the gene encoding dystrophins have long been known to cause the debilitating muscle-wasting disease Duchenne muscular dys
Oncology December 22,2023
New link between fatal muscle wasting disease gene and cancer discovered

New link between fatal muscle wasting disease gene and cancer discovered

byUniversity of PortsmouthCredit: Unsplash/CC0 Public DomainMutations of the gene encoding dystrophins have long been known to cause the debilitating muscle-wasting disease Duchenne muscular dys
Oncology December 22,2023
New gene target for aggressive lung cancer discovered

New gene target for aggressive lung cancer discovered

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNorthwestern Medicine scientists have identified and described a new gene that is responsible for activating an aggressive subtype of sm
Oncology December 22,2023
New gene target for aggressive lung cancer discovered

New gene target for aggressive lung cancer discovered

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNorthwestern Medicine scientists have identified and described a new gene that is responsible for activating an aggressive subtype of sm
Oncology December 22,2023
Druggable targets found for treating rare, deadly nerve cancer MPNST

Druggable targets found for treating rare, deadly nerve cancer MPNST

byCincinnati Children's Hospital Medical CenterTumor cell–state trajectories from NF to MPNST inferred by Slingshot. Arrows, transformation direction. Credit: Cincinnati Children's and S
Oncology December 22,2023
Druggable targets found for treating rare, deadly nerve cancer MPNST

Druggable targets found for treating rare, deadly nerve cancer MPNST

byCincinnati Children's Hospital Medical CenterTumor cell–state trajectories from NF to MPNST inferred by Slingshot. Arrows, transformation direction. Credit: Cincinnati Children's and S
Oncology December 22,2023
New factor in the development of hereditary kidney cancer discovered

New factor in the development of hereditary kidney cancer discovered

by Gabriele Meseg-Rutzen,University of CologneHira-andFh1-deficient cells promote tumor initiation, growth, and invasion in vivo.(A) Scheme of xenograft injections in the flank of nu
Oncology December 21,2023
New factor in the development of hereditary kidney cancer discovered

New factor in the development of hereditary kidney cancer discovered

by Gabriele Meseg-Rutzen,University of CologneHira-andFh1-deficient cells promote tumor initiation, growth, and invasion in vivo.(A) Scheme of xenograft injections in the flank of nu
Oncology December 21,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com